Boundless Bio, Inc. (BOLD)Healthcare | Biotechnology | San Diego, United States | NasdaqGS
1.58 USD
-0.05
(-3.067%) ⇩
(April 17, 2026, 4 p.m.
EDT)
After hours: 1.66 +0.08 (4.987%) ⇧ (April 17, 2026, 7:07 p.m. EDT) Short-term: ★★★★☆ | Long-term: ★★☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 19, 2026, 12:41 a.m. EDT
High-conviction short-term bounce play off accumulation, but an inadequate long-term buy due to persistent cash burn and negative EPS stripping value despite the specific drug therapies. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.071856 |
| AutoETS | 0.082706 |
| AutoTheta | 0.112336 |
| AutoARIMA | 0.127128 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 14% |
| H-stat | 4.32 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.000 |
| Excess Kurtosis | 7.52 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 49.704 |
| Market Cap | 35,403,460 |
| Forward P/E | -1.23 |
| Beta | -0.26 |
| Website | https://boundlessbio.com |
| Attribute | Value |
|---|---|
| 52 Week Change | 0.12857139 |
| Address1 | 10,955 Alexandria Way |
| Address2 | Suite 100 |
| All Time High | 15.24 |
| All Time Low | 0.961 |
| Ask | 1.63 |
| Ask Size | 1 |
| Average Daily Volume10 Day | 806,740 |
| Average Daily Volume3 Month | 227,303 |
| Average Volume | 227,303 |
| Average Volume10Days | 806,740 |
| Beta | -0.255 |
| Bid | 1.52 |
| Bid Size | 1 |
| Book Value | 4.403 |
| City | San Diego |
| Compensation As Of Epoch Date | 1,735,603,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 1.58 |
| Current Ratio | 8.743 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 1.6493 |
| Day Low | 1.57 |
| Debt To Equity | 49.704 |
| Ebitda | -62,301,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | 0.371 |
| Enterprise Value | -23,142,544 |
| Eps Current Year | -2.38333 |
| Eps Forward | -1.28333 |
| Eps Trailing Twelve Months | -2.6 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 1.177 |
| Fifty Day Average Change | 0.403 |
| Fifty Day Average Change Percent | 0.3423959 |
| Fifty Two Week Change Percent | 12.85714 |
| Fifty Two Week High | 1.78 |
| Fifty Two Week High Change | -0.19999993 |
| Fifty Two Week High Change Percent | -0.11235951 |
| Fifty Two Week Low | 0.961 |
| Fifty Two Week Low Change | 0.619 |
| Fifty Two Week Low Change Percent | 0.6441207 |
| Fifty Two Week Range | 0.961 - 1.78 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,711,632,600,000 |
| Float Shares | 16,359,310 |
| Forward Eps | -1.28333 |
| Forward P E | -1.2311721 |
| Free Cashflow | -31,409,000 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 28 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.11384 |
| Held Percent Institutions | 0.51257 |
| Implied Shares Outstanding | 22,407,251 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ipo Expected Date | 2,024-03-28 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Boundless Bio, Inc., a clinical-stage oncology company, develops interrogating extrachromosomal DNA (ecDNA) directed therapies for treating patients with oncogene amplified cancers. Its lead product candidate is BBI-940, an ecDNA-directed therapeutic candidate (ecDTx) that is in Phase 1/2 clinical trial in patients with estrogen receptor positive and human epidermal growth factor receptor 2 negative breast cancer, as well as patients with triple-negative breast cancer luminal androgen receptor subtype. The company was formerly known as Pretzel Therapeutics, Inc. and changed its name to Boundless Bio, Inc. in July 2019. Boundless Bio, Inc. was incorporated in 2018 and is headquartered in San Diego, California. |
| Long Name | Boundless Bio, Inc. |
| Market | us_market |
| Market Cap | 35,403,460 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_637641859 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -58,197,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 35,179,384 |
| Number Of Analyst Opinions | 1 |
| Open | 1.64 |
| Operating Cashflow | -46,661,000 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 858 766 9912 |
| Post Market Change | 0.07879996 |
| Post Market Change Percent | 4.9873395 |
| Post Market Price | 1.6588 |
| Post Market Time | 1,776,467,271 |
| Previous Close | 1.63 |
| Price Eps Current Year | -0.662938 |
| Price Hint | 4 |
| Price To Book | 0.35884625 |
| Profit Margins | 0.0 |
| Quick Ratio | 8.581 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.05 |
| Regular Market Change Percent | -3.06748 |
| Regular Market Day High | 1.6493 |
| Regular Market Day Low | 1.57 |
| Regular Market Day Range | 1.57 - 1.6493 |
| Regular Market Open | 1.64 |
| Regular Market Previous Close | 1.63 |
| Regular Market Price | 1.58 |
| Regular Market Time | 1,776,456,000 |
| Regular Market Volume | 349,096 |
| Return On Assets | -0.21856001 |
| Return On Equity | -0.46688998 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 22,407,251 |
| Shares Percent Shares Out | 0.0007 |
| Shares Short | 15,345 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 7,293 |
| Short Name | Boundless Bio, Inc. |
| Short Percent Of Float | 0.0011999999 |
| Short Ratio | 0.23 |
| Source Interval | 15 |
| State | CA |
| Symbol | BOLD |
| Target High Price | 4.0 |
| Target Low Price | 4.0 |
| Target Mean Price | 4.0 |
| Target Median Price | 4.0 |
| Total Cash | 107,581,000 |
| Total Cash Per Share | 4.801 |
| Total Debt | 49,035,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -2.6 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 1.197125 |
| Two Hundred Day Average Change | 0.38287508 |
| Two Hundred Day Average Change Percent | 0.31982884 |
| Type Disp | Equity |
| Volume | 349,096 |
| Website | https://boundlessbio.com |
| Zip | 92,121 |